Android app Apple app link

Is Lineage Cell Therapeutics (LCTX) the Best New Pick in Brad Gerstner's Portfolio?

By Yahoo! Finance   |   3 months ago
Is Lineage Cell Therapeutics (LCTX) the Best New Pick in Brad Gerstner's Portfolio?

Brad Gerstner's portfolio includes Lineage Cell Therapeutics, Inc. among 7 new stock picks. He expects the new administration to boost mergers and acquisitions in the US, promoting innovation and startups.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.